Stomatal development in Arabidopsis epidermis is both positively and negatively regulated by a family of Cys-rich peptides, EPIDERMAL PATTERNING FACTOR LIKEs (EPFLs). We synthesized biologically active synthetic EPFL5 (sEPFL5) peptide, which reduced the number of stoma in leaves and cotyledons. The sEPFL5 possesses three disulfide bonds at positions identical to those of a positive development factor, stomagen. Application of sEPFL5 had little inhibitory effect on protodermal cells entering the stomatal lineage, but did inhibit the maintenance of meristemoid activity, resulting in the differentiation of arrested meristemoids into pavement cells. This phenotype was enhanced in the too many mouths (tmm) mutant background. RNA analysis revealed that sEPFL5 application halved SPEECHLESS expression and abolished MUTE expression in tmm mutants, explaining the phenotype observed. The action of sEPFL5 was mediated by ERECTA family receptors. We propose that EPFL5 functions to establish the differentiation of stomatal lineage cells to pavement cells.
The stoma is a gas exchange system distributed on the surface of almost all above-ground organs among higher plants. Developmental processes of stomata have been well studied in Arabidopsis leaves and cotyledons. 1, 2) Stomatal development begins with the formation of an initial cell of stomatal lineage, called the meristemoid mother cell (MMC), in the protodermal layer. The MMC divides asymmetrically to form a meristemoid, which has characteristically small triangular shape, as well as a larger sister cell. This division is designated ''entry division.'' Meristemoid cells have a stem cell-like character. The cells undergo several rounds of asymmetric division (amplifying division) that reproduces a meristemoid as well as making a sister cell that is eventually converted into a guard mother cell (GMC). The GMC divides symmetrically, producing a pair of guard cells. The sister cells that divide from meristemoids become pavement cells, and sometimes initiate a new stomatal lineage by ''spacing division'' to create a satellite meristemoid and its sister cell. These proliferative sister cells and their descendant pavement cells are called stomatal lineage ground cells (SLGCs). 3, 4) Molecular genetic analysis has uncovered many genes involved in stomatal development. Three closely related basic helix-loop-helix (bHLH) transcription factors, SPEECHLESS (SPCH), MUTE, and FAMA, direct the three steps of cell-fate transition during stomatal development: MMC to meristemoid, meristemoid to GMC, and GMC to guard cells. [5] [6] [7] The epidermis of spch is made solely of pavement cells and lacks any stomatal cell lineage, whereas protodermal cells of mutants of each of the other two genes can enter the stomatal lineage. The mute produces a rosette-like pattern with an arrested meristemoid at the center, and the fama produces a stack of symmetrically divided GMC-like cells. Two additional bHLH proteins, SCREAM (SCRM, which is identical to ICE1) and SCRM2, have partially redundant functions and coordinate the activities of SPCH, MUTE, and FAMA by heterodimerization. 8) Another class of stomatal regulators is a family of leucine-rich-repeat receptor-like kinases consisting of ERECTA, ERECTA-LIKE1 (ERL1), and ERECTA-LIKE2 (ERL2), hereafter the ERECTA family. erecta erl1 erl2 triple mutants make stomatal clusters, and hence the ERECTA family proteins are thought to be involved in the one-cell spacing rule, in which stomata are separated by at least one intervening non-stomatal epidermal cell. 3) The stomatal cluster phenotype also appears in too many mouths (tmm) mutants. 9) The TMM gene encodes a leucine-rich-repeat receptor-like protein, which associates with the ERECTA family receptorlike kinases. 10, 11) As for ligands of these receptors, two homologous Cys-rich peptides, EPIDERMAL PATTERNING FACTOR1 (EPF1) and EPF2, have y To whom correspondence should be addressed. Fax: +81-52-789-4094; E-mail: guronyan@agr.nagoya-u.ac.jp Abbreviations: sEPFL5, synthetic EPFL5; MMC, meristemoid mother cell; GMC, guard mother cell; SLGC, stomatal lineage ground cell; bHLH, basic helix-loop-helix; MALDI-TOF MS, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; DIC, differential interference contrast; CLSM, confocal laser scanning microscope; PI, propidium iodide; GFP, green fluorescent protein; GUS, -glucuronidase; m=z, mass-tocharge ratio been identified. The predicted mature forms of the EPF1 and EPF2 peptides have been found to associate with the ERECTA and ERL1 proteins in vivo and in vitro. 11) EPF2, but not EPF1, also binds to TMM. 11) Downstream of the activated receptors, a mitogen-activated protein kinase cascade is thought to transmit the signal to transcriptional regulators such as SPCH. [12] [13] [14] Although both EPF1 and EPF2 inhibit stomatal development, the functions of these factors are distinct. EPF1 is expressed in meristemoid and GMCs, and overexpression of EPF1 confers arrest of stomatal lineage cells and increased production of pavement cells of various sizes. 15, 16) In contrast, the EPF2 promoter is active mainly in MMCs, and the epidermis of EPF2 overexpressors consists of relatively large pavement cells and lacks the small pavement cells that are produced by asymmetric division of stomatal-lineage cells. 16) The expression of marker genes revealed that both MMC and meristemoids disappeared in EPF2 overexpressors, while only meristemoids (and not MMC) disappeared in EPF1 overexpressors. epf1 mutants produce clustering of stomata, and epf2 mutants have increased numbers of both stomatal and pavement cells, but few stomatal clusters. Hence, it has been suggested that EPF1 acts as a cell-cell signal emitted by late-stomatal precursors preventing neighboring cells from developing stomata, and that EPF2 inhibits protodermal cells from becoming MMCs, which initiate stomatal lineages. 15, 16) The functional difference between EPF1 and EPF2 has been confirmed by application experiments in which bacterially produced and refolded peptides were applied to wild-type Arabidopsis seedlings. The EPF1 peptide conferred an epidermis devoid of stomata with arrested meristemoids, whereas the EPF2 peptide led to severe inhibition of asymmetric division needed to initiate stomatal lineages. 11, 17, 18) Nine other genes encode EPF-like peptides in the Arabidopsis genome: EPIDERMAL PATTERNING FACTOR LIKE1 (EPFL1) to EPFL9. Among these, STOMAGEN/EPFL9 is unique in that overexpression of it causes increased stomatal density and stomatal clustering. Gene silencing of STOMAGEN by RNAi reduces stomatal density in various organs. Thus, unlike EPF1 and EPF2, STOMAGEN acts as a positive regulator of stomatal development. 19, 20) The mature form of stomagen is a 45-amino-acid peptide corresponding to the C-terminal half of the precursor protein, and contains three pairs of disulfide bonds. 19) Threedimensional structural analysis by NMR revealed that stomagen is comprised of a loop, which confers functional specificity on this peptide, and a functionally indispensable scaffold, including the disulfide bonds. 21) Activity of stomagen is dependent on functional TMM. The STOMAGEN gene is expressed in mesophyll cells, suggesting that inner photosynthetic tissues regulate stomatal density by releasing stomagen. 19, 20) Another class of EPFLs, EPFL6/CHALLAH, EPFL5/CHALLAH-LIKE1, and EPFL4/CHALLAH-LIKE2, hereafter the CHAL family, have also been characterized. 22, 23) Overexpression of any of the CHAL family genes reduces stomatal numbers in cotyledons, and this phenotype is much enhanced in the tmm mutant background. While triple mutations of epfl4 epfl5 epfl6 show no change in stomatal formation, epfl4 epfl5 epfl6 tmm quadruple mutations cause the production of stomatal clusters in hypocotyls. In cotyledons, the quadruple mutants produce larger clusters of stomata than the tmm mutants. Thus the CHAL family is a negative regulator of stomatal formation, but the activity is inhibited by TMM. Elimination of stomata conferred by CHAL family overproduction can be alleviated by any double mutations between ERECTA family genes supplemented with tmm, indicating that the activity of the CHAL family is mediated by ERECTA family receptors. Direct interactions between CHAL family peptides and ERECTA family proteins have been idntified in vitro and in vivo. 23, 24) Promoter-GUS analysis revealed that CHAL family genes have overlapping yet distinct expression patterns in hypocotyls and developing stems, but no detectable expression in cotyledons or leaves. 22, 23) In inflorescence stems, expression of EPFL4 and EPFL6 is restricted to the endodermis. Plants bearing epfl4 epfl6 double mutations are defective in growth, as evident from short stature, shortened pedicels, and compact inflorescences, which all resemble the phenotype of erecta mutants. From these observations, it is believed that CHAL family members act as growth regulators coordinating inflorescence architecture, and that TMM prevents the CHAL family from regulating stomatal formation. 23, 24) However, our preliminary expression data showed that EPFL5 is highly expressed in leaves and cotyledons, suggesting the possibility that at least EPFL5 acts as a regulator of stomatal production. Furthermore, the higher order structures of bioactive EPFLs have not been determined to date, with the exception of stomagen, a unique activator of stomatal formation.
In the present study, we synthesized bioactive EPFL5 peptide, determined its structure, and evaluated its bioactivity. Downstream signaling of EPFL5 regulating stomatal repression was also characterized.
Materials and Methods
Plant materials. Arabidopsis thaliana (L.) Heynh. accession Col-0 was used as wild-type Arabidopsis unless otherwise indicated. tmm (SALK 011958) was obtained from the Arabidopsis Biological Resource Center. 15) scrm-D, 8) erecta erl1 erl2 (erecta-105 erl1-2 erl2-1), 25) EPF1:GFP, 16) and TMM:GUS-GFP 10) have been described previously.
Construction of plasmid and transgenic plants.
For overexpression of EPFL5, a genomic sequence was PCR-amplified with primers K22 and K23 (Supplemental Table 1 ; see Biosci. Biotechnol. Biochem. Web site) and cloned into pTK104, as described previously. 15) Arabidopsis was transformed using our standard procedure, 26) and the transformants were grown under a 12 h light-12 h dark photocycle at 22 C. The Ws-2 accession of Arabidopsis was used for EPFL5 overexpression.
Chemical synthesis and refolding of sEPFL5 peptide. sEPFL5 was synthesized by Fmoc solid-phase peptide synthesis with a peptide synthesizer (Initiator þ SP Wave, Biotage, www.biotage.com). Purification and refolding of the peptide was carried out as previously described. 19) Digestion and structural analysis of sEPFL5. Refolded sEPFL5 (340 pmol) was digested by means of Trypsin Gold (1 mg, Mass Spec grade, Promega, www.promega) and ProteaseMax (1 mg, Promega) in 50 mL of digestion buffer (40 mM ammonium bicarbonate in 10% acetonitrile) for 1 h at 50 C. Matrix-assisted laser desorption/ioniza-tion time-of-flight mass spectrometry (MALDI-TOF MS) and MS/MS data were acquired by Applied Biosystems 4700 Proteomics Analyzer (Life Technologies, www.lifetechnologies.com) with TOF/TOF ion optics. 19) Treatment of seedlings with sEPFL5. Refolded sEPFL5 dissolved in 0.01% acetic acid was filter-sterilized by passage through DISMIC03CP (Advantec, www.advantec.co.jp) and added to Gamborg's B5 medium (Nihon Pharmaceutical, www.nihon-pharm.co.jp) supplemented with 1% sucrose and adjusted to pH 5.7. To observe stomatal phenotype and marker gene expression, we sowed sterilized seed on the peptide-containing medium solidified with 0.7% agar, which was prepared in microcentrifuge tubes (0.5 mL size), and grew them for 3 d at 22 C under continuous illumination. When the cotyledons opened, liquid medium of the same composition (without agar) was added to immerse the growing seedlings. At 6 d, enlarged cotyledons were harvested and observed. Marker gene expression in the rosette leaves was observed at about 10 d after sowing. For RNA assay, 20-d-old tmm seedlings grown on agar medium (not supplemented with the peptide), from which leaves and roots longer than 2 mm had been removed, were transferred to a liquid medium containing 5 mM sEPFL5 and grown for 3 d. Newly emerged leaves were harvested and used in RNA preparation.
Microscopy and quantitative analysis of stomata. In the clearing method, cotyledons were fixed in ethanol:acetic acid (9:1) for 4 h, rinsed in water, and stained with 1 mg/mL of Safranin-O solution for 20 s. After removal of excess Safranin-O by rinsing in water, the samples were treated with chloral hydrate solution, chloral hydrate:water:glycerol (8:2:1, w/v/v). Differential interference contrast (DIC) images were captured by FV1000 confocal laser scanning microscope (CLSM) (Olympus, www.olympus.co.jp). Safranin-stained stomata were observed by CLSM with a 559-nm emission diode laser. In the propidium iodide (PI) method, cotyledons (or rosette leaves) were dipped in 0.1 mg/mL PI solution for 20 s and rinsed with water. The fluorescent signals from the PI-stained cell walls and green fluorescent protein (GFP) were observed under CLSM using 559-nm and 473-nm emission diode lasers, respectively. To quantify stomatal density, the numbers of stomata in two 0.40 mm 2 square areas were counted and averaged.
RNA preparation and quantification of mRNA. Harvested plant materials were immediately frozen in liquid nitrogen and used in RNA preparation by means of an RNeasy Plant mini kit (Qiagen, www.qiagen.com). Extracted RNA from each sample (0.2 mg) was used for reverse transcription with ReverTra Ace qPCR RT Master Mix with gDNA Remover (Toyobo, www.toyobo-global.com). Reverse transcripts were quantified by real-time PCR by the Applied Biosystems 7500 real-time PCR system (Life Technologies) and THUNDERBIRD SYBR qPCR mix (Toyobo). RNA yields and reverse transcription efficiencies were normalized by the amount of PDF2 mRNA (PP2AA3, At1g13320), which is known to be a constitutively expressed gene. 27) To determine the absolute amount of cDNA for each of the genes, known molar concentrations of PCR-amplified fragments corresponding to a gene were prepared and used as concentration standards for quantitative PCR. The primers used in quantitative PCR are listed in Supplemental Table 1 .
Results

Stomatal phenotype in EPFL5 overexpressors
In our previous study, we found that the stomatal density in leaf epidermis was lower in Arabidopsis plants overexpressing the EPFL5/CHALLAH-LIKE1 (At3g22820) gene. 16) We performed quantitative correlation analysis between expression level of the gene and the stomatal density in cotyledons. Plants expressing the EPFL5 gene 10 times or more above wild-type levels showed reduced stomata density in abaxial cotyledon epidermis (Fig. 1A) . The average value of stomatal density among the top five plants expressing EPFL5 highly was 7 times lower than that of wild type (Fig. 1B ). Although this stomatal phenotype in EPFL5 overexpressors has recently been reported, no detailed phenotypic analysis regarding stomatal development has been done. 23) We observed the epidermal morphology of one of the plants most highly expressing EPFL5 and compared it to that of the wild type ( Fig. 1C-F) . The overexpressor had only a few stomata as visualized by Safranin-O staining on abaxial cotyledon surface. We found the size of epidermal cells to be non-uniform. The large cells are likely to be non-stomatal lineage pavement cells, and smaller ones resembled developmentally arrested meristemoids with surrounding SLGCs. A and B, Correlation between the expression levels of EPFL5 and stomatal densities on the abaxial surface of fully expanded cotyledons. A, Scatter plot for 28 seedlings containing a transgene for EPFL5 overexpression (T2 generation, circles). The five plants with highest expression of EPFL5 are indicated by solid circles. Four wild-type (WT) seedlings (Ws-2 accession) are also scored (triangles). The expression level is shown by the value relative to the average of the wild-type plants, which was set to 1. B, Comparison of stomatal density between wild-type plants and the five plants with highest expression of EPFL5 (EPFL5ox). Individual results (symbols) and the averages (bar graphs) are shown. C and D, DIC images showing the abaxial cotyledon surfaces of a wild-type plant (C) and of an EPFL5 overexpressor (D). Specimens were prepared by the clearing method supplemented by Safranin staining. E and F, CLSM images of the same field as in C and D, showing Safranin-stained stomata in E. No stomatal signal was observed in F. In C to F, typical stomata (arrowheads), large pavement cells (black asterisks), and arrested meristemoids (white asterisks) are indicated. Scale bars represent 100 mm.
Expression of the EPFL5 gene By means of histochemical analysis, -glucuronidase (GUS) gene expression from the EPFL5 promoter was detected in a restricted region of the hypocotyls (surface proximal to the folded cotyledons and boundary between cotyledon and meristem) and young inflorescences, while no expression was observed in the cotyledons or leaves. 23, 24) However, tiling array data for CHAL family expression indicated relatively higher expression of EPFL5 gene in the leaves. 23) This discrepancy prompted us to examine the expression levels of EPFL5 in comparison with other CHAL family genes and STOMAGEN. We prepared RNA samples from roots, hypocotyls (including shoot apical meristems), and cotyledons of 6-d-old seedlings grown on agar plates; adult leaves (leaf blades of almost fully expanded first and second true leaves) and young leaves (those of emerging third and fourth true leaves) of 14-d-old seedlings grown on agar plates; and open flowers, all flower buds (including inflorescence meristems), and developing fruits at 3 d and 8 d after pollination, and stems (the top 1.5 cm of inflorescence stems including pedicels but not flowers or buds) of soil-grown adult plants. The amounts of transcripts for EPFL4, EPFL5, EPFL6, and STOMAGEN were measured by quantitative RT-PCR. To compare the transcript levels of the various genes, we determined the absolute amount of reversetranscript for each target gene in a first-strand cDNA mixture using known concentrations of DNA fragments as quantification standards. Assuming that the reverse transcription efficiency for all genes is constant, these amounts reflect the levels of mRNA of distinct genes in the same RNA sample. Furthermore, we normalized the reverse transcription efficiencies in different RNA samples using the mRNA levels of the constitutively expressed gene, PDF2, as internal standard. 27) Hence the results are indicated as relative values, which were calculated against the amount of EPFL5 transcript in the adult leaves, set to 1. High-level expression of EPFL5 was observed in hypocotyls, cotyledons, adult leaves, flowers, and fruits, while expression was weaker in young leaves and flower buds ( Fig. 2A ). While nearly the same level of expression was observed among the three CHAL family genes in many organs, the prominent characteristic of EPFL5 was high expression in cotyledons and adult leaves, where EPFL4 and EPFL6 were expressed at lower levels (Fig. 2B, C) . These results are consistent with the tiling array data. 23) Hence, we propose that EPFL5 contributes to certain events in cotyledons and leaves such as stomatal development. STOMAGEN was detected in all above-ground organs, with relatively high levels in cotyledons and leaves, 3-5 times higher than the levels of EPFL5 (Fig. 2D ).
Structural analysis of chemically-synthesized EPFL5 peptide
In order to determine the structure and function of EPFL5, we chemically synthesized a peptide, designated synthetic EPFL5 (sEPFL5), which corresponds to the C-terminal 51-amino-acid region of the putative EPFL5 precursor protein. This region was predicted based on the structure of stomagen. 19, 20) After refolding in the presence of glutathione and urea, the peptide was purified by HPLC and subjected to MALDI-TOF mass spectrometry.
We observed the typical ion at a mass-to-charge ratio (m=z) of 5,713 (½M þ H þ ), which corresponds to the calculated molecular mass of a predicted mature peptide that has three pairs of intramolecular disulfide bonds (Fig. 3A) . Then we attempted to determine the arrangement of the three disulfide bonds. After digestion with trypsin, we detected two peaks of m=z ¼ 1;190:5 and m=z ¼ 1;542:7, which were consistent with the predicted double-and triple-chain peptides connected by disulfide bonds, respectively (Fig. 3B ). By means of MS/MS analysis of the tryptic fragments, the predicted doublechain peptide was found to consist of Pro 1 -Arg 9 and Cys 42 -Lys 43 . Thus one disulfide bond appeared to connect Cys 8 (C 1 ) and Cys 42 (C 5 ) (Fig. 3C, E) . Likewise, MS/MS analysis produced signals indicating that the To compare the expression levels of a given gene in the various organs and also the levels of different genes in the same organs, the absolute number of mRNA molecules included in a unit amount of total RNA was estimated. The details of the estimation procedure are described in the text. All transcript levels are expressed as values relative to the level of EPFL5 expression in adult leaves, which was set to 1. Roots (R), hypocotyls (H), and cotyledons (C) of 6-d-old seedlings; expanding adult leaves (AL) and newly generated young leaves (YL) in 14 triple-chain peptide consisted of Leu 10 -Lys 14 , Cys 15 -Lys 19 , and Cys 44 -Lys 47 . We observed two distinct signals derived from double-chain fragments consisting of Leu 10 -Lys 14 and Pro 17 -Lys 19 (peak d in Fig. 3D ) and Cys 15 -Glu 16 and Cys 44 -Lys 47 (peak c in Fig. 3D ), which were produced by cleavage between Glu 16 and Pro 17 . Thus two residual disulfide bonds were determined to connect Cys 12 (C 2 ) with Cys 18 (C 4 ), and Cys 15 (C 3 ) with Cys 44 (C 6 ) ( Fig. 3E) . In sum, we confirmed that the same combination of Cys residues makes intramolecular disulfide bridges in both sEPFL5 and stomagen, although their primary structures are highly divergent (Fig. 3F ). 19, 20) 
Inhibition of stomatal development by sEPFL5
To test the biological activity of the refolded sEPFL5 peptide, wild-type Arabidopsis seed was sown on agar medium containing various concentrations of the peptide. When the cotyledons opened, liquid medium containing the peptide was added to immerse the whole seedlings until their cotyledons had fully expanded. With increases in the peptide concentration, stomatal density gradually decreased, consistently with the phenotype resulting from EPFL5 overexpressors, indicating that the peptide was biologically functional (Fig. 4A) . However, about 10% of stomata remained formed even when the highest concentration (20 mM) of peptide was applied, suggesting that its effect on wild-type plants was not very strong ( Fig. 4A ). Because it has been found that the active TMM gene represses the phenotype associated with overexpression of CHAL family genes including EPFL5, 23) next we applied sEPFL5 to tmm mutants. In the absence of the peptide, the tmm cotyledons made many clusters of stomata, but the stomatal numbers remarkably decreased at low concentrations (10 nM) of the peptide. High concentration (10 and 20 mM) treatment completely inhibited stomatal formation (Fig. 4A) . These results confirm that sEPFL5 has inhibitory activity on stomatal development, and that the activity is weakened by functional TMM.
Microscopic observation of wild-type cotyledons revealed that the stomata were replaced by small pavement cells in response to increased peptide concen- Cleavage sites corresponding to the signals are indicated by lower-case letters. Six Cys residues, designated C1 to C6, are shown. Superscripts represent the amino acid numbers indicated in (E). E, Structure of sEPFL5, which includes the arrangements of three disulfide bonds (red lines). Numbers represent the amino-acid numbers counting from the N-terminal end of this structure. Arrowheads indicate cleavage sites of trypsin digestion, while the peptide bond between Lys 11 and Cys 12 (white arrowhead) was hardly digested under our experimental condition. The peptide is color-coded according to the tryptic fragment. F, Comparison of primary structures between sEPFL5 and stomagen. Six Cys residues and other identical amino acid residues are indicated by colors. trations (Fig. 4B-D) , which is also similar to the phenotype associated with EPFL5 overexpression (Fig. 1D ). This phenotype was more pronounced in tmm mutants ( Fig. 4E-G) . The cotyledon epidermis treated with 1 mM peptide consisted of pavement cells of various sizes, indicating that the formation of stomata has been initiated but then aborted. In many cases, the smallest cell in a lineage was juxtaposed to a similarsized cell, suggesting that the final division of the lineage was nearly symmetric (cells labeled 5 and 6 in Fig. 4F 0 , for example). The smallest cells did not resemble GMCs; they were not oval and had a jigsaw periphery similar to pavement cells. When the tmm mutant was treated with 10 mM peptide, the small pavement cells were still identifiable, but were fewer in number. Based on these observations, we propose that sEPFL5 inhibits the maintenance of meristemoid activity to continue asymmetric division and to make GMCs, and has weak activity to inhibit the entry to stomatal development.
Mechanism of stomatal development inhibition by EPFL5 peptide
To establish the reason meristemoids lose their activity under sEPFL5 treatment, we observed the expression of stomatal marker lines. The lines used here did not have the tmm mutation. TMM:GUS-GFP was expressed in proliferative post-protodermal cells including early stomatal lineage cells (Fig. 5A ). 10) In the peptide-treated young leaves, the TMM:GUS-GFP was expressed in small epidermal cells, confirming the above observation that these were recently generated SLGCs (Fig. 5B) . EPF1:GFP was predominantly expressed in meristemoids and GMCs in untreated young leaves, 16) but the number of GFP-positive cells was markedly reduced in the peptide-treated leaves, suggesting that almost all meristemoids and GMCs had disappeared (Fig. 5C, D) . In sum, it was confirmed that sEPFL5 allows entry to the stomatal lineage but aborts the maintenance of meristemoids and/or GMC differentiation.
We evaluated the effects of application of sEPFL5 on the expression of genes involved in stomata formation. To achieve a clearer result by eliminating the inhibitory effect of TMM, we used tmm mutants in this experiment. Seedlings were immersed in liquid medium supplemented with 5 mM sEPFL5 for 3 d, and true leaves newly emerged during treatment were harvested and used for RNA preparation. We found that sEPFL5 completely eliminated the expression of MUTE and halved the mRNA levels of SPCH and FAMA (Fig. 6) . A lack of MUTE expression, which is required for promotion of the transition from meristemoid to GMC, explains the disappearance of GMCs in the cotyledons. Intriguingly, not only the expression of EPF1 but also the expression of EPF2 was repressed by sEPFL5 treatment (Fig. 6 ). Because EPF2 is expressed in GMCs, we suggest that the initiation of stomata formation was also inhibited. This is consistent with the partial reduction of SPCH expression. By contrast, expression of STOMAGEN and the CHAL family genes was not affected.
Previous genetic analysis revealed that the ERECTAfamily proteins are receptors for CHAL family peptides. 23, 24) This prompted us to examine whether the effect of EPFL5 was dependent on the presence of active ERECTA family proteins. As reported previously, the erecta erl1 erl2 triple mutants produced many clustered stomata on the cotyledons (Fig. 7A-C) . 3) No change in phenotype was observed even when the triple mutants were treated with 20 mM peptide (Fig. 7D) , indicating that the action of sEPFL5 on stomata development is mediated through the function of ERECTA-family receptors.
In the current model, expression of SPCH, MUTE, and FAMA is thought to be regulated by signaling pathways originating from the ERECTA family receptor kinases. 5, 6) scrm-D is an interesting mutation, because it brings about enhanced activation of stomatal-lineage entry, resulting in constitutive stomatal differentiation in the epidermis. In this mutant, many genes specific to stomatal lineage, including ERL1, TMM, SPCH, MUTE, and FAMA, are upregulated. 8) Hence, we treated the scrm-D mutants with EPFL5 peptide to determine whether the peptide could inhibit the functioning of scrm-D. The result was very clear, that stomatal overproduction in scrm-D leaves was not affected by peptide treatment (Fig. 7E, F) , suggesting that the repression of stomatal-lineage gene expression by sEPFL5 was overcome by the enhancing function of scrm-D.
Discussion
All 11 members of the EPF/EPFL family of genes are predicted to produce Cys-rich peptides that have six or eight conserved Cys residues, but the sequence homologies among the peptides are not very high. 16 ) Information on the higher-order structures of these peptides has been gained based only on analysis of stomagen, which has the unique activity of promoting stomatal production. However, at least five other peptides, EPF1, EPF2, EPFL4, EPFL5, and EPFL6, have an opposite function, i.e., inhibition of stomatal development. It is quite possible that the positive and negative factors have different structures. Hence, we determined the structure of the EPFL5 peptide, the overexpression of which provided an obvious stomataless phenotype in leaves. We preformed MALDI-TOF MS and MS/MS analysis of biologically active sEPFL5. Regardless of the opposite function, we found that sEPFL5 has three disulfide bonds at the same positions as those of stomagen. It is likely that the higher-order structures of all EPF/EPFL peptides are similar. Our result is consistent with a recent report that stomagen is composed of two modules, a loop and a scaffold containing three disulfide bonds. The loop accounts for the functional specificity of EPF/EPFLs, while the scaffold is structurally required for their activity. 21) Because the clustered stomata phenotype in erecta erl1 erl2 triple mutants was not affected by sEPFL5 treatment, we deduced that the action of EPFL5 is mediated through ERECTA family receptor kinases. A similar result has been reported that the phenotypes of CHAL family overexpressors are dependent on ERECTA family receptors. 22, 23) Furthermore, epfl4 epfl5 epfl6 triple mutants (in the presence of the tmm mutation) show a phenotype similar to erecta erl1 erl2 mutants in the hypocotyls. All these observations are consistent with direct interaction between CHAL family peptides and ERECTA family receptors. 23, 24) Both EPF1 and EPF2 bind to ERECTA and ERL1 in vitro, 11) suggesting functional equivalence among ERECTA family receptors in EPF action. Nevertheless, apparent receptor selectivity of EPF peptides was observed in vivo. Genetic analysis has revealed that the EPF2 activity is mediated by ERECTA and regulates the transition of protodermal cells to MMC, whereas the function of EPF1 requires ERL1 and directs the spacing division that generates satellite meristemoids. 11, 17) Thus the application of EPF2 peptide causes inhibition of asymmetric division, resulting in an epidermis composed solely of pavement cells. By contrast, application of EPF1 peptide causes inhibition of stomatal differentiation, resulting in an epidermis devoid of stomata, while asymmetric entry and amplifying divisions still occur. 11) As for sEPFL5, it repressed stomatal development dose-dependently in wild type and tmm mutants. Application of the peptide did not affect entry divisions, but remarkably inhibited GMC differentiation in wildtype seedlings. Treatment of tmm seedlings with low concentration of the peptide caused similar phenotype. These resembled the plants treated with EPF1 peptide. 11) In contrast, application of high concentration of sEPFL5 to tmm seedlings reduced both entry and subsequent asymmetric divisions, resulting in a phenotype that resembled EPF2-treated plants. 11) These results indicate that EPFL5 has dual functions: one is similar to EPF1, and the other but weaker function is similar to EPF2. It has been reported that active ERL1 and ERL2 were sufficient to inhibit GMC differentiation and entry divisions, respectively, in EPFL5 overexpression. 23) Hence we propose that EPF1 and EPFL5 use the same receptor (ERL1) to regulate GMC differentiation, while EPF2 and EPFL5 use different receptors (ERECTA and ERL2, respectively) to regulate entry divisions.
Another difference between EPFL5 and EPFs is opposite dependency on TMM. Both EPF1 and EPF2 absolutely require TMM in transmitting their signals through ERECTA family receptors, whereas the activity of CHAL family peptides is markedly weakened by the presence of functional TMM. Abrash et al. referred the latter function of TMM as insulator. 23) It has been found that both EPFL5 and EPF2 interact directly with TMM, and also with ERECTA and ERL1. 11, 23) Although TMM has been found to associate with ERECTA family proteins, and hence they are predicted to form heterodimeric receptor complexes, 11) it is largely unknown how TMM modulates the ligand specificity of its partners.
The cotyledon epidermis of wild-type seedlings treated with sEPFL5 peptide consisted of pavement cells of various sizes, indicating that the formation of SLGCs was initiated. Expression of TMM:GUS-GFP in the small cells of sEPFL5-treated leaves confirms this interpretation. However, as shown by the absence of EPF1:GFP expression, meristemoids were arrested and differentiated into pavement cells. We found that the expression of SPCH was halved and that MUTE expression was almost eliminated in sEPFL5-treated leaves. In general, SPCH initiates the stomatal lineage by enforcing entry division and continues subsequent asymmetric division by maintaining the stem-cell activity of meristemoids. 5, 6) Thus a weak allele of spch can initiate entry division at slightly reduced frequency, but the meristemoids soon terminate asymmetric division. 6 division of meristemoids. 5, 6) Hence we interpreted the phenotype of sEPFL5-treated plants as follows: Entry division is affected by a reduction in SPCH expression only when the concentration of the peptide is high. After a few rounds of asymmetric division, meristemoids no longer divide due to insufficient SPCH activity. Reduced MUTE activity might rather promote the asymmetric division. Finally, the arrested meristemoids differentiate to pavement cells, but not to GMCs, since MUTE expression is abolished. An odd aspect of this model is the relatively large contribution of SPCH, because its expression was only halved (a half of active transcript remained) in the plants treated with the peptide. Recently, it was found that SPCH activity is regulated by phosphorylation mediated by a protein kinase cascade downstream of ERECTA family receptors. 14) Thus the phosphorylation levels of SPCH might also be affected by sEPFL5 treatment.
As for the relationship between the functions of ERECTA family receptors and bHLH transcription factors, the EPF2-ERECTA pathway leading to SPCH repression appeared to be simple, because the phenotype of EPF2 overexpression, which is mediated by ERECTA, is almost identical to the phenotype of spch mutants. 11) However, EPF1 overexpression mediated by ERL1 causes a combined phenotype of spch and mute, 11) indicating the occurrence of crosstalk between the EPF1-ERL1 and the EPF2-ERECTA pathways. To date, neither the expression levels of bHLH transcription factors nor the phosphorylation levels of SPCH have been determined in plants overexpressing EPFs or in plants treated with EPF peptides. It would be interesting to compare our results with those.
Treatment with sEPFL5 did not affect the phenotype of scrm-D. Because the phenotypes of the double mutants comprising scrm-D and spch, mute, or fama are different from the mutants of scrm-D, 8) it is likely that the expression of SPCH, MUTE, and FAMA was not affected by the application of sEPFL5. This indicates that the constitutively active form of SCRM induces the expression of other bHLH transcription factors independently of the signaling mediated by ERECTA family receptors.
Although recent papers have proposed that the function of CHAL family is to regulate inflorescence architecture rather than stomatal development, the contribution of EPFL5 to this function is less than that of the other two CHAL family members (EPFL4 and EPFL6). 23, 24) EPFL5 is expressed in the leaves and cotyledons, where STOMAGEN is also highly expressed. Moreover, when TMM activity is reduced, CHAL family strongly represses stomatal development. Thus, our model indicates that EPFL5 contributes to the prevention of excess formation of stomata by inhibiting the re-entry of differentiating SLGCs in which the expression of TMM is decreased. Other CHAL family members may have similar functions in hypocotyls, stems, and floral organs, where these genes are expressed.
